International Journal of Drug Delivery Technology
Volume 16, Issue 2s

Optimization Of Metformin Pulsatile Drug Delivery System Using Central Composite Design

Ravali V1, Balaji P2*

1Research scholar, School of Pharmaceutical Sciences, VISTAS, Pallavaram, Chennai, Tamil Nadu, India, 600117
2*Department of Pharmacology, School of pharmaceutical sciences, VISTAS, Pallavaram, Chennai, Tamil Nadu, India, 600117

ABSTRACT

Objective: The aim of the study was to create a pulsatile multiparticulate system of metformin to be optimized in the delivery of chronotherapeutic drugs.

Methods: Metformin pulsatile beads were made and optimized based on the BoxBehnken design with polyvinylpyrrolidone (PVP, X₁) and ethyl cellulose (EC, X₂) as the independent variables. The particle size, polydispersivity index (PDI), entrapment efficiency, lag-time and drug release were analyzed.

Results: EC had a substantial effect on particle size, lag time and drug release whereas PVP primarily had an effect on entrapment efficiency and matrix hydration. Per cent percentage of drug release was 68.4 ± 0.31 and 88.4 ± 0.48, and lag time 0.5 ± 0.02 h to 4.5 ± 0.06 h. The MP4 formulation, which was optimized (PVP 1.0 mg, EC 6 mg) was found to have a particle size of 1336.0 ± 3.6 nm, PDI of 0.794 + 0.06 and entrapment efficiency of 98.50 + 0.52, lag time of 0.5 + 0.03 h, and drug release of 88.4 + 0.48.

Conclusion: The optimized pulsatile system exhibited a short lag time with a rapid release of the drug, therefore, it can be considered an effective chronotherapeutic delivery system of metformin.

Keywords: Metformin; Pulsatile drug delivery; Chronotherapy; Ethyl cellulose; Polyvinylpyrrolidone; Response surface methodology; Multiparticulate beads; Box–Behnken design

How to cite this article: Ravali V, Balaji P., Optimization Of Metformin Pulsatile Drug Delivery System Using Central Composite Design. Int J Drug Deliv Technol. 2026;16(2s): 308-322; DOI: 10.25258/ijddt.16.308-322